{
  "response": {
    "text": "Based on the search results, a study comparing thalidomide vs. thalidomide plus interferon alfa (IFN\u03b1) exists.\n\nAccording to \"[1] Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: A\", Chiou is a possible author of a relevant study.\n\nReferring to \"[3] Lenalidomide use in multiple myeloma (Review) - Spandidos Publications.\", Ya-Nan Wang is the second author for this article.\n\nTherefore, SAWang\n",
    "citations": [
      "http://www.ncbi.nlm.nih.gov/pubmed/24580409"
    ]
  }
}